Actuant will sell the segment to Sentinel Capital Partners.
Day: October 31, 2013
Pharmaceutical declines from expired contracts impacted results.
The company began a new expanded contract with Walgreen Co. during the fourth quarter.
During the first nine months, DXP spent $61 million on acquisitions.
Multi-family residential new construction continued to be a bright spot.